Product Images Ramipril
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Ramipril NDC 70518-3038 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
Ramipril is a medication available in capsule form with a concentration of 10mg. The package comes with 90 capsules that are only available through a prescription. The medication was manufactured by Aurcbindo Pharma Ltd in Hyderabad, India. The package insert should be consulted for directions for use. The medication should be stored between 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) [See USP]. The medication's lot number, NDC #, and expiration date are not available. It is advised to keep the medication out of the reach of children. The package was repackaged by RemedyRepack Inc. in Indiana, PA.*
Figure 1. Kaplan-Meier Estimates of the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes in the Ramipril Group and the Placebo Group - ramipril fig1
This appears to be a graph or chart with the title "Ramipril" and a scale on the x-axis labeled "Days of Follow-up" ranging from 0 to 1500. The y-axis is not labeled but has tick marks for 0.0, 0.1, and 0.2. There are five data points, at approximately 500-day intervals, with values of 0.2, 0.1, 0.1, 0.0, and 0.0 respectively. There is also a note indicating that P=0.0001. It is possible that this represents a study or experiment measuring the proportion of patients experiencing some outcome over time while taking ramipril.*
Figure 2. The Beneficial Effect of Treatment with Ramipril on the Composite Outcome of Myocardial Infarction, Stroke, or Death from Cardiovascular Causes Overall and in Various Subgroups - ramipril fig2
This text appears to be a table with information about patients and various medical conditions including cardiovascular disease, diabetes, hypertension etc. The table also includes information about the number of patients and incidence of composite outcome in the placebo group. The relative risk in the Ramipril group is also mentioned with a 95% confidence interval.*
Chemical Structure - ramipril str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.